Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for CO2-induced panic in Panic Disorder
NCT02593682Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in panic disorder, sponsored by University of California, San Francisco. Started May 2016; status: completed.
02
Drugs
suvorexant
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT02593682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593682.